Navigation Links
New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures

Data Presented at the American Academy of Neurology Annual Meeting Show Approximately 50 Percent Reduction in Partial Seizures

BOSTON, May 01, 2007 /PRNewswire/ -- Data from two clinical trials presented today at the American Academy of Neurology (AAN) meeting suggest that an investigational once daily extended release formulation of Lamictal(R) (lamotrigine) is effective as add-on treatment in patients with partial epilepsy with and without secondary generalization. Lamictal XR Extended- Release Tablets are currently in development for the treatment of epilepsy. If approved, it will be the first extended release, new generation epilepsy treatment taken once-daily.

Data from the ARMOR study, an international, multi-center, randomized, double-blind, placebo-controlled trial, showed that the new once-daily, extended release formulation reduced partial seizures by 46 percent, while patients taking placebo experienced a reduction of 24 percent over the entire 19-week treatment period. The study also showed significant overall reduction in seizure frequency in both the escalation and maintenance treatment phases. In addition, the study showed that 42 percent of patients treated with Lamictal XR reduced their frequency of seizures by at least half by the end of the 19-week treatment period.

The second study, COMPASS, showed that patients could be switched from Lamictal(R) immediate release (IR) to Lamictal XR while maintaining comparable blood levels of lamotrigine.

"These data are important because they show that the extended release formulation of Lamictal reduces the frequency of seizures. The once daily dosing regimen may also provide a more convenient treatment option for patients," said Dean Naritoku, M.D., Professor of Neurology and Pharmacology, Southern Illinois University, Springfield, IL. "In addition, when compared to Lamictal immediate release, given twice a day, the new investigatio
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
2. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
3. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
4. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
5. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
6. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
7. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
8. CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
9. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
10. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
11. New Poll Shows Men, Women Incorrectly Blame Symptoms of Low Testosterone on Normal Aging

Post Your Comments:
(Date:11/26/2009)... , JOHANNESBURG, South Africa, Nov. 26 /... Africa Company of the Year Award in the Generic P...South Africa Limited. ,, (Logo: http://www.new...the Company of the Year Award, the following crite...nce against key competitors: growth strategy and i...
(Date:11/25/2009)... , WESTON, Fla., Nov. 25 /PRNewswire-F...ink Sheets: ASFX) ("the Company") is pleased to an...and production management office in Shanghai, Chin...road, providing an essential gateway for the devel... and safety products for children and adults to be...
(Date:11/25/2009)... , BEDFORD, Mass., Nov. 25 /PRNewswire-Fi... (Nasdaq: HOLX ), a leading developer, manufactur...aging systems and surgical products dedicated to s... annual meeting of the Radiological Society of Nor...ovember 29 through December 3, 2009 to highlight o...
Breaking Medicine Technology:Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4American Scientific Resources Inc. Opens Shanghai Location 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4FDA Activates VPCI Electronic Registration Account 57462 1FDA Activates VPCI Electronic Registration Account 57462 2Max Muscle Franchising Is Fueled By The Passion Behind The Brand 57460 1Max Muscle Franchising Is Fueled By The Passion Behind The Brand 57460 2Max Muscle Franchising Is Fueled By The Passion Behind The Brand 57460 3Stemedica 26apos 3Bs President Delivers Keynote Address At Swiss Russian Forum 57458 1Stemedica 26apos 3Bs President Delivers Keynote Address At Swiss Russian Forum 57458 2Stemedica 26apos 3Bs President Delivers Keynote Address At Swiss Russian Forum 57458 3
... - Several SSRIs more than double risk of cancer r...arly 30 percent of tamoxifen users take drugs that... , ORLANDO, Fla., May 30 An important new study f...ly prescribed to women taking the breast cancer dr... cancer recurrence for those using both medication...
... - Phase 3 study has demonstrated that Induction C...ly increased time-to-treatment failure in comparis...ID, May 30 The Spanish Head and Neck Cancer Coope... Chemotherapy (IC) delivered prior to standard Che... as sequential therapy, compared to upfront CRT al...
Other Medicine Technology:New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer 2New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer 3New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer 4New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer 5Induction Chemotherapy Followed by ChemoRadiotherapy Increased Time-to-Treatment Failure Compared to ChemoRadiotherapy Alone in Patients With Unresectable Locally Advanced Head & Neck Cancer 2Induction Chemotherapy Followed by ChemoRadiotherapy Increased Time-to-Treatment Failure Compared to ChemoRadiotherapy Alone in Patients With Unresectable Locally Advanced Head & Neck Cancer 3
(Date:11/27/2009)...RNewswire-FirstCall/ -- The Gymboree Corporation (...COO, will present at the NASDAQ OMX 23rd Investor ...in London, England, on Wednesday, December 2, 2009...adcast of The Gymboree Corporation,s presentation ...om, click on "Our Company" at the bottom of the pa...
(Date:11/27/2009)...ov. 27 Shamir Optical In...ng provider of innovative products and technology ...t its board of directors had declared a dividend d...on (approximately NIS 37.62 million based on the N... or approximately US$ 0.609 (approximately NIS 2.3...
(Date:11/27/2009)... medical, economic burdens, study predicts , ...ber of people with diabetes in the United States i... study predicts. , That would bring the total b...se, up from 23.7 million today. , , At the same ...ll triple, the study also warns, rising from an es...
(Date:11/27/2009)...ose bilingual coloring books designed for children...mmunity to educate - inform parents and children a...o Dinosuars to ABC,S and a host of other topics. ...November 27, 2009 -- Today’s children have e...sy any hour of the day, but one of the oldest and ...
(Date:11/26/2009)...swire/ -- With cold and flu season upon us, it,s m...o control the spread of infections and avoid illne...p ourselves healthy, but to avoid transmitting ill...CIC (certified in infection-control), nursing dire... at Hospital for Special Surgery (HSS) in Manhatta...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4
... Are you one of the,more than 68 million people wh... Academy of Orthopaedic Surgeons (AAOS) challenges...OS application, available for download,on Facebook... (promoting weight-bearing exercises), Track thos...
...ul "Bear" Bryant,Awards committee of the American ...or the 2008 College Football Coach of the Year. Th... event chairmen, Bryant family,representatives, Na...finalists list will be announced and comprised of ...
...icaid Health Plans of,America (MHPA), the leading ...edicaid health plans, today extended its congratul...oric victory in becoming the 44th,President of the...ident-Elect Obama has a strong vision for expansio...
... A new study suggests that genetic factors influe...in, which could in turn be partly responsible for ... It appears that the size of the right orbitofront...ults who have several relatives that are alcohol d...
... Interleukin Genetics,Inc., (Amex: ILI ), announc...ebcast on Thursday, November 13, 2008, at 4:30 pm ...ancial results and provide an update on,recent cor...e teleconference,will be available on the Investor...
...nd Survey Findings Disclosed at Nov. 7 Webcast, B...unprecedented market ups and downs, life sciences ...argets, and overall spending. As a,result, emergin...utive compensation programs and processes. These i...
Other Medicine News:Health News:Get Ready to Get Up, Get Out and Get Moving! 2Health News:Bryant College Football Coach of the Year Watch List Released 2Health News:Impulse control area in brain affected in teens with genetic vulnerability for alcoholism 2Health News:Interleukin Genetics Announces Conference Call and Webcast to Discuss Third Quarter 2008 Business Results 2Health News:2008 Compensation and Entrepreneurship Report Highlights Executive Compensation Trends at Emerging Life Sciences Firms 2Health News:2008 Compensation and Entrepreneurship Report Highlights Executive Compensation Trends at Emerging Life Sciences Firms 3Health News:2008 Compensation and Entrepreneurship Report Highlights Executive Compensation Trends at Emerging Life Sciences Firms 4
Sterile Blades
Rish Cartilage Knife
Ballenger Swivel Knife
Sheehy-House Knife-Curette
Medicine Products: